Home » Roche Launches SARS-CoV-2 Mutation Test for Use in Research
Roche Launches SARS-CoV-2 Mutation Test for Use in Research
Devices COVID-19 Research and Development
Roche has released its cobas SARS-CoV-2 Variant Set 1 Test, a COVID-19 diagnostic that can detect and differentiate between the UK, South African and Brazilian variants of the coronavirus.
The laboratory test is intended for research use only to help scientists in tracking the prevalence of the mutations and their potential effect on diagnostics, vaccines and therapeutics.
The test runs on the company’s cobas 6800/8800 systems and features ready-to-use cassettes and pre-defined software parameters. Roche said that its existing SARS-CoV-2 tests are not negatively impacted by the currently known SARS-CoV-2 mutations.